Clinical Evaluation of Radiation Reduction for Optimized Safety

Launched by ANGIOWAVE IMAGING · Mar 31, 2024

Keywords

ClinConnect Summary

This clinical trial is designed to explore a new approach to taking heart images called angiograms, which are important for diagnosing heart conditions like coronary artery disease and chest pain. The study aims to see if using a method that significantly reduces radiation exposure can still produce high-quality images, similar to traditional methods that use higher radiation doses. This could lead to safer procedures for patients undergoing heart assessments.

To be eligible for this trial, participants must be at least 18 years old, referred for a coronary angiogram, and able to understand and sign a consent form. However, some individuals, such as those experiencing urgent heart issues or with certain medical histories, may not qualify. Participants in the study will have their heart images taken using the new low-radiation technique and will be monitored for any related effects. This trial is currently not recruiting patients, but it aims to make heart imaging safer for everyone in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Referred for clinically indicated coronary angiography
• • ≥18 years of age
• • Not pregnant
• • English speaking
• • Not imprisoned
• • Able to provide written informed consent
• Exclusion Criteria:
• • Hemodynamically or electrically unstable.
• • Indication for coronary angiography is emergent, including ST-segment elevation myocardial infarction
• • History of coronary artery bypass grafting
• • An eGFR \<60
• • Pregnant or lactating
• • A BMI of 45 or greater
• • Any other factor that the investigator feels would put the patient at increased risk or otherwise make the patient unsuitable for participation in the protocol